Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce C Carleton

Showing results (21-30 of 134) with videos related to

Pageof 14
Sort By:
American Journal of Ophthalmology|December 25, 2015
Risk of Myocardial Infarction and Stroke With Single or Repeated Doses of Intravitreal Bevacizumab in Age-Related Macular DegenerationMahyar Etminan, David A Maberley, David W Babiuk, et al.
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|February 9, 2013
The use of long-acting β2- agonists as monotherapy in children and adultsPat G Camp, Tingting Zhang, M Anne Smith, et al.
American Journal of Ophthalmology|April 21, 2016
Risk of Myocardial Infarction and Stroke With Single or Repeated Doses of Intravitreal Bevacizumab in Age-Related Macular DegenerationMahyar Etminan, David A Maberley, David W Babiuk, et al.
Pharmacoepidemiology and Drug Safety|April 6, 2013
High use of health services in patients with suboptimal asthma drug regimens: a population-based assessment in British Columbia, CanadaTingting Zhang, M Anne Smith, Pat G Camp, et al.
Annual Review of Pharmacology and Toxicology|October 2, 2020
Challenges and Opportunities in Implementing Pharmacogenetic Testing in Clinical SettingsWan-Chun Chang, Reo Tanoshima, Colin J D Ross, et al.
Frontiers in Genetics|March 6, 2015
Use of pharmacogenomics in pediatric renal transplant recipientsMara Medeiros, Gilberto Castañeda-Hernández, Colin J D Ross, et al.
International Clinical Psychopharmacology|August 2, 2017
Risk of hair loss with different antidepressants: a comparative retrospective cohort studyMahyar Etminan, Mohit Sodhi, Ric M Procyshyn, et al.
Therapeutic Drug Monitoring|September 12, 2024
Implementation and Evaluation Strategies for Pharmacogenetic Testing in Hospital Settings: A Scoping ReviewAngela Wu, Edward J Raack, Colin J D Ross, et al.
Therapeutic Drug Monitoring|February 2, 2023
Development of a Dose-Adjusted Polygenic Risk Model for Anthracycline-Induced CardiotoxicityAngela Siemens, Shahrad Rod Rassekh, Colin J D Ross, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|February 14, 2007
Paediatric adverse drug reaction reporting: understanding and future directionsBruce C Carleton, M Anne Smith, Michaela N Gelin, et al.
Pageof 14

Showing results (21-30 of 134) with videos related to

Sort By:
Pageof 14
American Journal of Ophthalmology|December 25, 2015
Risk of Myocardial Infarction and Stroke With Single or Repeated Doses of Intravitreal Bevacizumab in Age-Related Macular DegenerationMahyar Etminan, David A Maberley, David W Babiuk, et al.
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|February 9, 2013
The use of long-acting β2- agonists as monotherapy in children and adultsPat G Camp, Tingting Zhang, M Anne Smith, et al.
American Journal of Ophthalmology|April 21, 2016
Risk of Myocardial Infarction and Stroke With Single or Repeated Doses of Intravitreal Bevacizumab in Age-Related Macular DegenerationMahyar Etminan, David A Maberley, David W Babiuk, et al.
Pharmacoepidemiology and Drug Safety|April 6, 2013
High use of health services in patients with suboptimal asthma drug regimens: a population-based assessment in British Columbia, CanadaTingting Zhang, M Anne Smith, Pat G Camp, et al.
Annual Review of Pharmacology and Toxicology|October 2, 2020
Challenges and Opportunities in Implementing Pharmacogenetic Testing in Clinical SettingsWan-Chun Chang, Reo Tanoshima, Colin J D Ross, et al.
Frontiers in Genetics|March 6, 2015
Use of pharmacogenomics in pediatric renal transplant recipientsMara Medeiros, Gilberto Castañeda-Hernández, Colin J D Ross, et al.
International Clinical Psychopharmacology|August 2, 2017
Risk of hair loss with different antidepressants: a comparative retrospective cohort studyMahyar Etminan, Mohit Sodhi, Ric M Procyshyn, et al.
Therapeutic Drug Monitoring|September 12, 2024
Implementation and Evaluation Strategies for Pharmacogenetic Testing in Hospital Settings: A Scoping ReviewAngela Wu, Edward J Raack, Colin J D Ross, et al.
Therapeutic Drug Monitoring|February 2, 2023
Development of a Dose-Adjusted Polygenic Risk Model for Anthracycline-Induced CardiotoxicityAngela Siemens, Shahrad Rod Rassekh, Colin J D Ross, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|February 14, 2007
Paediatric adverse drug reaction reporting: understanding and future directionsBruce C Carleton, M Anne Smith, Michaela N Gelin, et al.
Pageof 14